Kura Oncology, Inc.

Kura Oncology, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Kura Oncology, Inc. is not a good growth stock. Kura Oncology, Inc. is not very popular among insiders. Kura Oncology, Inc. is a mediocre stock to choose.
Log in to see more information.
Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company which engages in the rese...
KURA Fundamental Data by TradingView

News

Cantor Fitzgerald Reiterates Overweight Rating for Kura Oncology (NASDAQ:KURA)
Cantor Fitzgerald Reiterates Overweight Rating for Kura Oncology (NASDAQ:KURA)

Ticker Report Kura Oncology (NASDAQ:KURA - Get Free Report)s stock had its "overweight" rating reiterated by equities researchers at Cantor Fitzgerald in a report released on Monday, Benzinga reports. Other...\n more…

Kura Oncology to Participate in Cantor Global Healthcare Conference
Kura Oncology to Participate in Cantor Global Healthcare Conference

Globe Newswire SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...\n more…

Kura Oncology, Inc. (NASDAQ:KURA) Short Interest Up 12.3% in August
Kura Oncology, Inc. (NASDAQ:KURA) Short Interest Up 12.3% in August

Zolmax Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) saw a large growth in short interest in August. As of August 15th, there was short interest totalling 10,400,000 shares, a growth of 12.3% from...\n more…

Short Interest in Kura Oncology, Inc. (NASDAQ:KURA) Increases By 12.3%
Short Interest in Kura Oncology, Inc. (NASDAQ:KURA) Increases By 12.3%

Ticker Report Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) was the target of a large increase in short interest in the month of August. As of August 15th, there was short interest totalling 10,400,000...\n more…

Kura Oncology (NASDAQ:KURA) Lowered to "Sell" at StockNews.com
Kura Oncology (NASDAQ:KURA) Lowered to "Sell" at StockNews.com

Zolmax StockNews.com lowered shares of Kura Oncology (NASDAQ:KURA - Free Report) from a hold rating to a sell rating in a research report sent to investors on Thursday morning.\nKURA has been the topic of a...\n more…

Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of "Buy" from Brokerages
Kura Oncology, Inc. (NASDAQ:KURA) Receives Consensus Recommendation of "Buy" from Brokerages

Ticker Report Shares of Kura Oncology, Inc. (NASDAQ:KURA - Get Free Report) have been given a consensus recommendation of "Buy" by the six research firms that are presently covering the stock, MarketBeat Ratings...\n more…